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 Strabismus, or squint, is a common heterogeneous group
of disorders including both divergent (exotropia) and conver-
gent (esotropia) deviations of one or both eyes. It is caused by
a variety of factors. The estimates of familial incidence vary
considerably with the population and specific phenotype stud-
ied and range from 13% to 65% with an average around 30%
[1]. Concordance rates in monozygotic twins also vary with
the study, but average around 75% while the concordance rate
for dizygotic twins is around 35% [1]. Thus it is thought to
have a major genetic component but environmental factors
such as low birth weight, maternal cigarette smoking, and lack
of breast-feeding have been shown to play a contributory role
[2,3]. Congenital esotropia is defined as a convergent devia-
tion of the eyes occurring within the first 6 months of life [4],
and is associated with poor potential for binocular single vi-
sion even if the eyes are aligned surgically from a young age.
It has an incidence of 1-2%, [5].
The inheritance of congenital esotropia was studied in
detail by Maumenee et al [6]. There was good evidence for
classical autosomal recessive inheritance in most pedigrees.
However, statistical analysis indicated the most likely mode
of inheritance to be a Mendelian codominant model, although
the disorder was unable to be modelled as a multifactorial trait.
Nelson et al. presented evidence that strabismus is inherited
as either an autosomal recessive or an autosomal dominant
trait with incomplete penetrance [5].
While the genetic causes of strabismus and congenital
esotropia are currently unknown, there are several animal
models of the disorder that may provide clues. Most mamma-
lian species studied have albino variants. Oculocutaneous Al-
binism (OCA) is a recessive genetic disorder of the melanin
pigmentary system, resulting in a reduction of pigment in the
skin, hair, and eyes. Melanin is produced in the melanosome
from tyrosine through a series of reactions involving enzymes
such as tyrosinase and tyrosinase-related protein 1 [7]. Reces-
sive mutations of the genes encoding these enzymes as well
as the P gene (a multifunctional membrane protein involved
in melanogenesis through a variety of mechanisms [8]) have
been found to be responsible for various forms of OCA in
mammals, including humans [7]. A feature of OCA is the
misrouting of retinal ganglion cell fibres at the optic chiasm
believed to be caused by a lack of melanin during develop-
ment [9,10]. Temporal retinal fibres cross the chiasm when
they should remain uncrossed resulting in inappropriate con-
nections in the visual cortex and a lack of binocularly driven
cells [10].
Siamese cats have a form of OCA (OCATs) caused by a
temperature sensitive form of tyrosinase, such that pigment is
only formed in the cooler parts of the body such as the ears
and nose. Additionally, Siamese cats frequently have a con-
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Purpose: Esotropia is a feature of albinism. Amongst esotropic patients there may be mild unrecognised albinos.
Oculocutaneous albinism shares several clinical features with congenital esotropia. It is well known that mammals with
oculocutaneous albinism have misrouted retinal ganglion cell axons, most likely caused by the absence of melanin or
DOPA during development. We investigated the hypothesis that mutations in the albinism genes Tyrosinase, the P Gene,
and TYRP1 may also be responsible for congenital esotropia via a similar mechanism.
Methods: We screened these three genes in 21 families with congenital esotropia using single stranded conformational
polymorphism analysis.
Results: No rare sequence variants segregating with esoptopia were detected. A novel silent mutation of the TYRP1 gene
was identified in one pedigree but is not likely to be causative. Several previously reported common polymorphisms were
detected but do not segregate with disease in this population.
Conclusions: Rare mutations of these genes do not appear to be responsible for congenital esotropia. Although we found
no evidence for segregation of common variants with disease, these require further investigation for a possible contribu-
tion to a complex threshold model. Several lines of evidence indicate a genetic componenet of congenital esotropia,
however, this is the first investigation of candidate genes for this disorder.
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vergent strabismus, absence of binocular vision, and misrouted
retinal ganglion cell fibres, as with OCA [11-13]. Similar tem-
perature sensitive mutations are also found in humans [14,15].
When such a mutation is present in humans in conjunction
with a null mutation on the other chromosome, ocular albi-
nism (OA) often results [16]. This disorder has the ocular fea-
tures of OCA although patients appear to be normally pig-
mented. Hence, mutations of the genes involved in melanin
synthesis can affect the development of the optic chiasm with-
out affecting overall pigmentation.
The hypothesis presented here is that strabismus, and spe-
cifically congenital esotropia, is caused by a similar molecu-
lar mechanism as OCA. The misrouting of fibres in OCA is
associated with the strabismus and a severe lack of binocular
vision, a recognised feature of congenital esotropia. The
misrouting of fibres in OCA is readily detectable by neuro-
physiological techniques such as Visual Evoked Potential
(VEP) studies. Studies of congenital esotropia patients using
VEP have given inconclusive results, with some showing no
abnormalities while others show definite misrouting [17-19].
Several of these studies suffer from poor classification of the
phenotype. Also, the abnormality may be too small to detect
with this commonly used method and more sensitive tech-
niques may be necessary. To investigate this hypothesis at a
molecular level we screened the three albinism genes for mu-
tations in a collection of families with congenital esotropia.
METHODS
 Ethical approval for this study was obtained from the Human
Research Ethics Committees of the University of Tasmania
and the Royal Hobart Hospital.
Patients:  Buccal swabs were collected from affected and
unaffected family members from families with 2 or more in-
dividuals affected with congenital esotropia in Tasmania, Aus-
tralia. All participants or their guardians gave informed con-
sent and were examined by one of two orthoptists (R.M.W or
J.M.B). Only families that met stringent diagnostic criteria
for congenital esotropia were included in this study. These
criteria included onset of strabismus within the first 12 months
of life, poor to absent binocular function, and the presence of
known associated anomalies such as dissociated vertical de-
viation (DVD), and latent nystagmus. Genomic DNA was
extracted from buccal swabs collected from participants us-
ing the PureGene DNA isolation kit (Gentra Systems, Minne-
apolis, MN, USA).
Primer extension preamplification:  Primer Extension
Preamplification (PEP) [20] was used to provide sufficient
DNA from buccal mucosa swabs to screen the three genes
using single stranded conformational polymorphism (SSCP)
analysis. Each 50 µl reaction contained 50-100 ng of template
DNA, 1000 pmol of random PolyN 15mer primer (Operon
Technologies, Alameda, CA, USA), 200 µM dNTPs
(Promega), 2 mM Mg2+ and 5 U of Taq Polymerase (Promega,
Madison, WI, USA). The reactions were initially denatured at
94 °C for 2 min, then amplified over 50 cycles of 92 °C for 1
min, 37 °C for 2 min, and 55 °C for 4 min with a final exten-
sion of 72 °C for 10 min. The presence of high molecular
weight product was confirmed by electrophoresis on 1% aga-
rose gel. All samples were then diluted to 25-50 ng/µl for SSCP
analysis.
Single stranded conformational polymorphism analysis:
Both forward and reverse primers were end labelled with γ32P-
ATP by T4 Polynucleotide Kinase (New England Biolabs,
Beverly, MA, USA). Each exon was amplified by PCR in 10
µl reaction volumes using the primers and annealing tempera-
tures detailed in Table 1 [21-23]. Each reaction contained 1.5
mM final concentration of Mg2+, 0.7 µM unlabelled and 0.11
µM labelled primer, 200 µM dNTPs, 0.5U Taq Polymerase
(Promega) and 50 ng of DNA. Reactions were denatured at
94 °C for 1 min, followed by 30 cycles of 94 °C for 40 s, 60
°C for 40 s, and 72 °C for 40 s with a final extension of 72 °C
for 5 min. Exon 15 of the P Gene was amplified in the pres-
ence of 5% DMSO.
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TABLE 1. PCR AMPLIFICATION OF ALBINISM GENES
                                            Primer sequence 5'-3'   Size of PCR    Annealing
   Gene                 Exons                   or reference          product     temperature
----------   ----------------------------   ---------------------   -----------   -----------
Tyrosinase   1A,1B,2-5                      [22]                                      52
             1C                             [22]                                      65
             Enhancer                       GGCAAGTGTAAGGCAAAATTC       315           58
                                            TTTGAGACAGAACAGGCTTTG
             Promoter                       TACCTCTCATTTGCAAGGTCA       400           58
                                            TCACAGATTTCTCTTTCCAGC
P Gene       2,3,6,7,10,11,14,16-18,21,24   [21]                                      58
             4,9                            [21]                                      65
             5                              ATGGAAGTTACTCAAGGCTGC       217           60
                                            TATACAGCCAAAGGCACACAG
             8,12,13,19,25                  [21]                                      56
             15                             [21]                                      60
             20                             [21]                                      50
TYRP1        1 (including promoter)         CCAAATTAGTGCTTCTGGC         360           60
                                            CTAATGGAGTTTTGGCACG
             2-8                            [23]                                      55
Primer sequences for PCR amplification of albinism genes were designed or taken from the literature as indicated. Exon 1 of Tyrosinase gene
was amplified in three overlapping fragments. The optimal annealing temperature is given.
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PCR products (5 µl) were added to 35 µl of SSCP stop
solution consisting of 95% deionised formamide, 10 mM
NaOH, 0.25% Bromophenol blue, 0.25% Xylene Cyanol (all
reagents supplied by Sigma-Aldrich, St Louis, MO, USA),
denatured at 95 °C for 2 min, and snap cooled on ice. Two µl
was loaded onto a 0.4 mm, 0.5X Mutation Detection Enhance-
ment (MDE) Gel (Edwards Instrument Co, Sydney, NSW,
Australia) and electrophoresed at 10 W for 20 h for 300-400
bp fragments and 8 W for 16 h for 200-300 bp fragments. The
gel was exposed to X-ray film for 24 h, before developing.
All family samples and affected individual samples were
compared to unaffected unrelated control samples. Differences
in the migration pattern between samples were further inves-
tigated by repeated SSCP and sequence analysis of genomic
DNA.
DNA sequence analysis:  PCR products were generated
using the same primers as for SSCP, but without the radioac-
tive label, and cycle sequenced using Big Dye Terminator
Ready Reaction Mix (Applied Biosystems, Foster City, CA,
USA). They were electrophoresed on an ABI 310 Genetic
Analyzer (Applied Biosystems).
Restriction fragment length polymorphism:  All samples
were genotyped at the codon 192 polymorphism of the tyrosi-
nase gene. A proportion of exon 1 was amplified using PCR
designed by Giebel and Spritz [24] in a reaction volume of 30
µl. Each reaction contained 1.5 mM Mg2+ final concentration,
200 µM dNTPs and 1.2 µM of each primer. Samples were
initially denatured at 94 °C then 30 cycles of 94 °C for 40 s,
55 °C for 40 s and 72 °C for 1 min. With a final extension of
72 °C for 10 min. 10 µl of PCR product was digested with 0.5
units of DpnII (New England Biolabs) and electrophoresed
on 1% agarose. Both alleles give a band at 177 bp. A 344 bp
product represents the undigested TAT allele and the 247 and
87 bp products represent the TCT allele.
Statistical analysis:  Polymorphisms identified were
analysed in informative triads for linkage disequilibrium with
disease using the Pedigree Disequilibrium Test (PDT) [25].
RESULTS
Patients:  Ascertainment is ongoing. At the time of this analy-
sis, the collection consisted of 122 individuals in 21 families
with 57 individuals affected with congenital esotropia. There
were 11 families with a single affected sibling pair, 4 families
with an affected sibling pair and an affected parent, 3 families
with 3 affected siblings, and 3 families of 3 generations with 2
or more affected individuals. Five families also contained in-
dividuals with other forms of strabismus such as exotropia
and dissociated vertical deviation.
Tyrosinase:  All 5 coding exons of tyrosinase were
screened as were the 5' promoter and enhancer regions [26].
The previously reported common polymorphism Y192S [24]
was not detected by SSCP analysis, but was shown to be present
in the population by sequence analysis. Frequencies of 0.48
for the TAT alleles and 0.52 for the TCT allele have been re-
ported [24]. All study participants were genotyped at this poly-
morphism using an RFLP generated by digestion with DpnII.
The Pedigree Disequilibrium Test (PDT) did not provide any
evidence that the Y192S polymorphism is associated with con-
genital esotropia (Table 2).
A variant of exon 4 was detected by SSCP analysis. Se-
quence analysis showed the variation to be the common poly-
morphism R402Q, a known temperature-sensitive mutation
[15]. The wild type sequence at this codon is CGA (coding for
arginine), with the CAA (glutamine) codon representing around
75% decrease in in vitro enzyme activity at 37 °C [16]. The
reported allele frequencies are 0.85 and 0.15, respectively [15].
No evidence of association was found using the PDT (Table
2).
The genotype data for both these common polymorphisms
were combined to give haplotypes for each individual. These
combined data were analysed using the PDT and also did not
provide any evidence that any of the haplotypes are associ-
ated with congenital esotropia (Table 2).
P gene:  The 24 coding exons of the P gene were screened.
Exon 1 is not translated [21] and was not examined. The analy-
sis detected three polymorphisms, one each in exons 10, 13,
and 24 (Table 2). The polymorphisms detected in exons 10
and 24 are in the coding region but have no effect on the pri-
mary sequence of the protein. The polymorphism in exon 13
changes codon 419 from arginine to glutamine (R419Q). This
has been previously reported as a common polymorphism with
no affect on protein function [21] and again, does not segre-
gate with disease. There were no families informative for the
PDT at any of these polymorphisms. During the investigation
of exons 13, 17, and 22, flanking intronic polymorphisms were
detected (Table 2). These do not interfere with splice sites and
show no correlation with disease phenotype. In summary, none
of the polymorphisms detected appear to be associated with
congenital esotropia.
Tyrosinase-related protein 1:  All eight exons and the pro-
moter of this gene were screened, excluding the non-coding
region of exon 8. One polymorphism was found by SSCP
analysis of exon 3 of this gene in two individuals, an unaf-
fected mother and one of her affected sons, but not the second
affected sibling. Sequence analysis of exon 3 showed that both
individuals were heterozygous (A/G) at the third nucleotide
of codon 158, coding for leucine, of the TYRP1 gene. This
polymorphism was not detected in 24 unaffected controls, nor
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TABLE 2. POLYMORPHISMS IDENTIFIED IN ALBINISM GENES
                                               Chi
   Gene             Exon          Position   squared   p value     Reference
----------   ------------------   --------   -------   -------   -------------
Tyrosinase            1            S192Y       2.3     0.1319        [24]
                      4            R402Q       2.5     0.1138        [15]
             combined haplotype                1.0     0.3173
P Gene               10            A355                              [21]
                     13            R419Q                             [21]
                     13            +26*                              [21]
                     17            -47*                              [21]
                     22            +25*                              [21]
                     24            S788                              [21]
TYRP1                 3            L158                          novel variant
All novel and previously reported polymorphisms detected in this
study are given. Where informative trios were available, the Pedi-
gree Disequilibrium Test was applied and the Chi squared and p val-
ues are given. The two common variants of tyrosinase were also com-
bined into a haplotype. No associations were significant. Asterisks
(*) indicate the number of nucleotides before the start (-) or past the
end (+) of the exon indicated.
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in any of the 102 other affected individuals. This polymor-
phism has not been previously described. TYRP1 mutations
did not appear to be associated with congenital esotropia in
this population.
Primer extension preamplification:  The PEP method was
validated by comparing SSCP of 3 exons of the P-gene using
both PEP DNA and genomic DNA. No differences were seen.
Any exons that showed a shift using PEP DNA were repeated
using genomic DNA to confirm the shift, before sequencing
using genomic DNA as template. No shifts were observed with
PEP DNA that were not present using genomic DNA.
DISCUSSION
 Although there is evidence that there is a genetic component
of congenital esotropia, this is the first investigation of candi-
date genes in this disease. The genes were chosen on the basis
of a plausible novel hypothesis with a biological basis. How-
ever, our investigation provided no evidence for a significant
contribution of these genes to congenital esotropia as we did
not detect many novel mutations. Those that were detected
did not segregate with the phenotype in those pedigrees. This
suggests that rare mutations of the albinism genes are not a
common cause of congenital esotropia.
Known common mutations were detected in the family
collection. The R402Q mutation of tyrosinase is known to af-
fect the temperature sensitivity of the enzyme such that pig-
ment is only produced at a reduced temperature such as that
found on the extremities [16]. No functional significance has
been attributed to the S192Y polymorphism of tyrosinase or
the R419Q polymorphism of the P protein. Due to strict col-
lection criteria (in an attempt to reduce the genetic heteroge-
neity) the family collection in this study had limited power to
evaluate association with the common polymorphisms. No
significant PDT results were obtained as there were limited
numbers of informative pedigrees.
The observation of autosomal recessive inheritance is sup-
ported in our family collection, although a dominant model
with incomplete penetrance may be possible, particularly in
the larger families. It is also very likely that congenital esotro-
pia is a multigenic heterogeneous disorder also involving en-
vironmental factors, making detection of the contributing genes
more difficult. Therefore, it is still possible that the common
mutations detected here make a contribution to a threshold
model of disease.
Buccal mucosa swabs are a common source of DNA from
children in studies of paediatric disorders. However, they pro-
vide only small quantities of DNA, generally in the range 2-8
µg. Primer Extension Preamplification (PEP) is a useful tech-
nique for providing sufficient DNA from low yielding buccal
mucosa swabs for analysis. This technique is not commonly
in use for mutation screening due to the fear of introducing
mutations during the preamplification step. The results of this
study indicate that the probability of false positive results is
very low. In addition, previous studies have found the tech-
nique to be reliable for allele typing [27,28]. The fact that PEP
can greatly increase the amount of DNA available makes buc-
cal mucosa swabs a more useful source of DNA, thus reduc-
ing the need to collect blood samples from children.
The hypothesis that congenital esotropia and other forms
of strabismus are caused by misrouted retinal ganglion cell
fibres requires further investigation. Other genes involved in
the melanin synthesis pathway may also be involved. For ex-
ample tyrosinase-related protein 2 is involved in the later stages
of melanin synthesis. This gene has not been associated with
albinism, but mutations may have an affect on melanin levels
during development and could possibly lead to the misrouting
discussed here. The MATP (membrane associated transport
protein) gene product is a membrane-spanning transporter
molecule with homology to plant sucrose symporters. A mu-
tation has been detected in one human patient with OCA (now
classified as OCA4) and several mutations have been identi-
fied in hypopigmented mice strains [29,30]. The transporter
appears to be necessary for normal melanin production. The
Microphthalmia-associated transcription factor (MITF) is in-
volved in the up-regulation of tyrosinase expression and is
crucial for the development of pigment cells [26]. Mutations
of the gene are known to cause Waardenburg syndrome type 2
in humans, which involves pigment abnormalities [31]. A dif-
ferent spectrum of mutations could be involved in the etiol-
ogy of congenital esotropia. Genes involved directly in the
development of the optic chiasm and the routing of retinal
ganglion fibres are also candidates. There are many genes in-
volved in this process. For example, Pax-2, Sonic Hedgehog,
L1, and CD44 are all known to play a role in optic chiasm
development [32-34].
The genetic origins of congenital esotropia and strabis-
mus in general have been recognised for some time, but the
molecular mechanisms remain elusive. VEP studies of the rout-
ing of fibres in strabismus patients have been inconclusive,
due mainly to poor definition of the phenotype undergoing
investigation and the lack of sensitivity of this method to de-
tect small changes. Our laboratory is undertaking a functional
MRI study of congenital esotropia patients to investigate the
routing of fibres in severe cases as this technique may be more
sensitive. Recruitment of congenital esotropia cases, and where
possible, their families, is ongoing in order to investigate the
common polymorphisms detected on a larger data set, includ-
ing triads and case-controls in addition to larger families. As
well, we have a large collection of individuals and families
with all common forms of strabismus that can be used to in-
vestigate candidate genes in these other forms of strabismus.
The development of this valuable resource will assist in the
gene discovery process. It is important to detect the genes in-
volved in this common disorder in order to unlock the mo-
lecular mechanisms and develop treatments and management
techniques based on the underlying causes.
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